66 related articles for article (PubMed ID: 35689631)
21. Eukaryotic translation initiation factor 4AIII (eIF4AIII) is functionally distinct from eIF4AI and eIF4AII.
Li Q; Imataka H; Morino S; Rogers GW; Richter-Cook NJ; Merrick WC; Sonenberg N
Mol Cell Biol; 1999 Nov; 19(11):7336-46. PubMed ID: 10523622
[TBL] [Abstract][Full Text] [Related]
22. Computational inference of eIF4F complex function and structure in human cancers.
Wu S; Wagner G
Proc Natl Acad Sci U S A; 2024 Jan; 121(5):e2313589121. PubMed ID: 38266053
[TBL] [Abstract][Full Text] [Related]
23. Mutational analysis of plant cap-binding protein eIF4E reveals key amino acids involved in biochemical functions and potyvirus infection.
German-Retana S; Walter J; Doublet B; Roudet-Tavert G; Nicaise V; Lecampion C; Houvenaghel MC; Robaglia C; Michon T; Le Gall O
J Virol; 2008 Aug; 82(15):7601-12. PubMed ID: 18480444
[TBL] [Abstract][Full Text] [Related]
24. The Triticum Mosaic Virus 5' Leader Binds to Both eIF4G and eIFiso4G for Translation.
Roberts R; Mayberry LK; Browning KS; Rakotondrafara AM
PLoS One; 2017; 12(1):e0169602. PubMed ID: 28046134
[TBL] [Abstract][Full Text] [Related]
25. Assessing eukaryotic initiation factor 4F subunit essentiality by CRISPR-induced gene ablation in the mouse.
Sénéchal P; Robert F; Cencic R; Yanagiya A; Chu J; Sonenberg N; Paquet M; Pelletier J
Cell Mol Life Sci; 2021 Oct; 78(19-20):6709-6719. PubMed ID: 34559254
[TBL] [Abstract][Full Text] [Related]
26. The Hsp90 inhibitor geldanamycin abrogates colocalization of eIF4E and eIF4E-transporter into stress granules and association of eIF4E with eIF4G.
Suzuki Y; Minami M; Suzuki M; Abe K; Zenno S; Tsujimoto M; Matsumoto K; Minami Y
J Biol Chem; 2009 Dec; 284(51):35597-604. PubMed ID: 19850929
[TBL] [Abstract][Full Text] [Related]
27. Crystal structure of the MIF4G domain of the Trypanosoma cruzi translation initiation factor EIF4G5.
Camillo Dos Santos LP; de Matos BM; de Maman Ribeiro BC; Zanchin NIT; Guimarães BG
Acta Crystallogr F Struct Biol Commun; 2019 Dec; 75(Pt 12):738-743. PubMed ID: 31797815
[TBL] [Abstract][Full Text] [Related]
28. Computational inference of eIF4F complex function and structure in human cancers.
Wu S; Wagner G
bioRxiv; 2023 Aug; ():. PubMed ID: 37609226
[TBL] [Abstract][Full Text] [Related]
29. Targeting Oncogene mRNA Translation in B-Cell Malignancies with eFT226, a Potent and Selective Inhibitor of eIF4A.
Thompson PA; Eam B; Young NP; Fish S; Chen J; Barrera M; Howard H; Sung E; Parra A; Staunton J; Chiang GG; Gerson-Gurwitz A; Wegerski CJ; Nevarez A; Clarine J; Sperry S; Xiang A; Nilewski C; Packard GK; Michels T; Tran C; Sprengeler PA; Ernst JT; Reich SH; Webster KR
Mol Cancer Ther; 2021 Jan; 20(1):26-36. PubMed ID: 33037136
[TBL] [Abstract][Full Text] [Related]
30. The mRNA translation initiation factor eIF4G1 controls mitochondrial oxidative phosphorylation, axonal morphogenesis, and memory.
Kim SH; Choi JH; Marsal-García L; Amiri M; Yanagiya A; Sonenberg N
Proc Natl Acad Sci U S A; 2023 Jun; 120(25):e2300008120. PubMed ID: 37307456
[TBL] [Abstract][Full Text] [Related]
31. Functional overlap between eIF4G isoforms in Saccharomyces cerevisiae.
Clarkson BK; Gilbert WV; Doudna JA
PLoS One; 2010 Feb; 5(2):e9114. PubMed ID: 20161741
[TBL] [Abstract][Full Text] [Related]
32. Adenosine 5'-O-(3-thio)triphosphate (ATPgammaS) is a substrate for the nucleotide hydrolysis and RNA unwinding activities of eukaryotic translation initiation factor eIF4A.
Peck ML; Herschlag D
RNA; 2003 Oct; 9(10):1180-7. PubMed ID: 13130132
[TBL] [Abstract][Full Text] [Related]
33. HuD stimulates translation via eIF4A.
Chen CY; Shyu AB
Mol Cell; 2009 Dec; 36(6):920-1. PubMed ID: 20064457
[TBL] [Abstract][Full Text] [Related]
34. Differential Regulation of the Melanoma Proteome by eIF4A1 and eIF4E.
Joyce CE; Yanez AG; Mori A; Yoda A; Carroll JS; Novina CD
Cancer Res; 2017 Feb; 77(3):613-622. PubMed ID: 27879264
[TBL] [Abstract][Full Text] [Related]
35. Advances in Understanding the Mechanism of Cap-Independent Cucurbit Aphid-Borne Yellows Virus Protein Synthesis.
Truniger V; Pechar GS; Aranda MA
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139425
[TBL] [Abstract][Full Text] [Related]
36. Broad anti-pathogen potential of DEAD box RNA helicase eIF4A-targeting rocaglates.
Obermann W; Azri MFD; Konopka L; Schmidt N; Magari F; Sherman J; Silva LMR; Hermosilla C; Ludewig AH; Houhou H; Haeberlein S; Luo MY; Häcker I; Schetelig MF; Grevelding CG; Schroeder FC; Lau GSK; Taubert A; Rodriguez A; Heine A; Yeo TC; Grünweller A; Taroncher-Oldenburg G
Sci Rep; 2023 Jun; 13(1):9297. PubMed ID: 37291191
[TBL] [Abstract][Full Text] [Related]
37. Non-canonical mRNA translation initiation in cell stress and cancer.
Mahé M; Rios-Fuller T; Katsara O; Schneider RJ
NAR Cancer; 2024 Jun; 6(2):zcae026. PubMed ID: 38828390
[TBL] [Abstract][Full Text] [Related]
38. Eukaryotic Initiation Factor 4E (eIF4E) as a Target of Anti-Psoriatic Treatment.
Golob-Schwarzl N; Pilic J; Benezeder T; Bordag N; Painsi C; Wolf P
J Invest Dermatol; 2024 Mar; 144(3):500-508.e3. PubMed ID: 37865179
[TBL] [Abstract][Full Text] [Related]
39. Novel eIF4A1 inhibitors with anti-tumor activity in lymphoma.
Kayastha F; Herrington NB; Kapadia B; Roychowdhury A; Nanaji N; Kellogg GE; Gartenhaus RB
Mol Med; 2022 Sep; 28(1):101. PubMed ID: 36058921
[TBL] [Abstract][Full Text] [Related]
40. Architecture, domain organization, and functional signatures of trypanosomatid keIF4A1s and
Dadwal A; DAS S
J Biosci; 2023; 48():. PubMed ID: 38018538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
